EPCAM and neoplasm: Tumors with VVlow not subjected to any preoperative ADT (i.e., tumors of hormone-naïve subcohort of patients) less frequently expressed the epithelial cell marker EpCAM in tumor cells (n = 296, Chi-squared = 10.314, p = 0.016, Figure 3A) and were usually characterized by the higher Gleason score (n = 585, Chi2 = 25.116, p < 0.001, Figure 3B).